Worldwide News

AnteoTech has developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests. These can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes. The tests use AnteoTech’s patented AnteoBind activated europium technology and provide significantly higher sensitivity than that offered by currently available COVID-19 tests. AnteoTech intends for the tests to […]

Evotec and Centogene have expanded their drug discovery partnership related to the protein target glucocerebrosidase (GBA) with a focus on Gaucher disease. This is a genetic and relatively common lysosomal storage disorder. The parties intend to develop a treatment option for the majority of patients whereas currently available treatments are individualised for each patient depending […]

Chemspec Europe, which was scheduled to take place in Cologne, Germany from 11 to 12 November 2020 has been postponed. Its new dates are 19 – 20 May 2021. The exhibition will occupy Hall 12.1 at Messe Frankfurt in Germany. This decision was taken after extensive conversations with all exhibitors and partners over recent weeks […]

19 August 2020 Image: CDC Bespoke custom contract service offers rapid access to broad range of high-quality antigen panels for influenza A and B viruses The Native Antigen Company has introduced a custom contract service to rapidly develop antigen panels for influenza A and B viruses. This new service offers scientists access to high-quality proteins […]

A study early in the global coronavirus pandemic evidenced the benefits of using steroids to combat COVID-19 According to researchers at the UK’s University of Huddersfield, a study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives, Dr Hamid Merchant […]

Bold Therapeutics has released data on the novel antiviral BOLD-100. In a series of experiments conducted by Dr Stephen Barr, Associate Professor in the Department of Microbiology and Immunology at Western University, BOLD-100 and remdesivir were tested head-to-head in a cytopathic effect assay against a live Wuhan strain of SARS-CoV-2 (COVID-19) in Vero E6 cells. […]

18 August 2020 Image: Drew Hays Scientists at EPFL have demonstrated the mechanism that allows cells to fight off viral DNA without triggering an immune response against their own genetic material. Viruses multiply by injecting their DNA into a host cell. Once it enters the intracellular fluid, this foreign material triggers a defense mechanism known […]

Enterprise Therapeutics is a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease. It has successfully dosed the first subjects in a Phase 1 trial for its novel inhaled cystic fibrosis therapy, ETD002. The first-in-man safety study is being conducted in healthy participants […]

18 August 2020 Image: Jude Beck Finding could lead to genetic tests that identify infants at risk for the disease New research supported by the US National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the […]

17 August 2020 Image: Cytonn Photography Sanofi has agreed to buy Principia Biopharma, a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases for $3.7 billion. “This acquisition advances our ongoing R&D transformation to accelerate development of the most promising medicines that will address significant patient needs,” said Paul Hudson, Sanofi Chief Executive Officer. […]